Model Organisms : Organoids- an emerging technology full of promises, by Dylan Liabeuf

Modelling is an essential part of the scientific method. A model enables us to learn about our surroundings by simplifying complex observations. Through this means, a set of operational or conceptual principles can be emphasised. Furthermore, statements can be deciphered, tested and challenged to get the most of an initial thought or proposal. The first recorded uses of an animal living model, were in a faraway era when scientists can go hand and hand with a philosopher, would seem to date from ancient Greece with Aristotle & Erastratus. Naturally, ever since the animal modelling has evolved both scientific-wise and in the guidelines that rule the field –ethics-. Past centuries observed an increase in the number of species used for a wide variety of novel domains. 

To keep it simple, scientists rely on small-animals to study genetics and developmental biology, whereas large living beings are used widely for therapeutic development. Lastly but not least, cellular models –not the whole body- are tailored to study diseases and develop medicines.

-The Organoid Model, an emerging technology full of promises-

An organoid can be defined by a miniaturised structure resembling whole organs at a three-dimensional level. It can be generated from different sources such as adult organ progenitors, e.g. tissue-resident adult stem cell, or from different types of pluripotent stem cells such as induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs). This organ-like framework can exhibit multiple cell types that are able to self-assemble and organise (organ morphogenesis) on their own or driven in different ways. The resulting entities are complex and mimic somehow their in-vivo counterparts.
Once generated from progeny, organoids can be furtherly differentiated and matured following the hallmarks of embryogenesis, organogenesis and even ageing. These features make this model a unique and unprecedented tool to model an outstanding variety of organisms, diseases and provide the opportunity to recapitulate human development. Thanks to the origin of the cells that compose the miniaturised organ, it turns that this model has acquired a prominent place in old: Diagnostics, Drug Discovery and Drug Testing - and new fields: Disease and Infection modelling, Precision/Personalised/Regenerative Medicine. Moreover, it appears that this technology is also currently included in an extensive range of clinical practice routine (Cystic Fibrosis, for example). Furthermore, several leading laboratories envisage using organoids as alternative organ replacement strategies (just like me).

In numbers of instances, organoids come out to be an alternative to animal experiment; capable of, at least, reducing the number of animals used in research. In fact, this emerging tool allows us to address a large number of initial questions thanks to characteristics such as the fantastic topology of cell-to-cell and cell-to-matrix interactions as observed in vivo. Undergone with animal cells at a first instance, the technology quickly moved towards human organ modelling. 

Nowadays, organoids from the three germ layers have been developed from patient-derived tissues as well as differentiated from pluripotent stem cells.
Embryonic germ layers

Intestinal organoids are recognized to be the first-ever launched by Prof. Hans Clevers. Benefiting from the discovery of intestinal stem cells, his lab developed the first mouse organoid in 2009 and human gut organoid in 2011. An outstanding amount of publications and findings took roots from his work. I am one of those, currently trying to develop a novel therapeutic solution for SBS (Short Bowel Syndrome) patients in the context of a European collaboration –INTENS- via the investigation of the development and functional maturation of human pluripotent stem-cell-derived gut organoids. A myriad of other endodermal organs has been developed since then such as liver lungs or the upper part of the gastrointestinal tract.

In the same “vein”, another organ has been modelled recently, the heart. Its development originates from another germ layer, the mesoderm, giving rise to muscles, bones and the circulatory system. It is astonishing to see the beats of the heart muscle, and even more mesmerising still a full plate of beating heart cells!

As major representant of the last germ layer, the neuroectoderm, and arguably considered as the most important organ of the human body, cerebral organoids sprung up. Considering the complexity of the brain due to the multiple issues towards its investigation, such tool as been wanted for years. Lancaster, Knoblich and Muotri’s labs are leading the optimisations and innovations within this pretty insane field. Among other unprecedented experiments, mini-brains have been interconnected and seems to communicate, microgravity brain impact has been accessed in space thanks to acollaboration with NASA.

Other 3D structures are closely related to organoids but lack a compulsory essence of the tool –to model an organ-, include gastruloids or tumouroid. Organ-on-a-chip systems are also being developed. Overall it is hoped these 3D cellular systems, in conjunction with organoids, could give insightful and unique opportunities to unravel unanswered scientific questions.

Novel 3D cell culture, Source: Pasca, Nature

Dylan's colleagues!

Of note, the Ludovic Vallier lab, part of the Cambridge Stem Cell Institute is undertaking responsive research to COVID-19. Dr. Fotios Sampaziotis -Clinical Lecturer and Hepatologist- and other members of the team resort to the organoid he developed a few years ago, i.e. cholangiocyte ones,  to study the mechanism the virus is utilizing to enter the cells. The Liver being the an organ of interest for this pandemic and the expertise of my lab. You can watch an interview with Dr. Sampaziotis here .


Comments